Ovarian Cancer; Questions to Ask

NWHRC Health Center - Ovarian Cancer, May 30, 2006

Review the following 'Questions To Ask' about ovarian cancer so you're prepared to discuss this important health issue with your health care professional.

How would I know if I have ovarian cancer?

What is the stage of my cancer and what does it mean?

What sort of treatment do you recommend and why?

What sort of risks are associated with those treatments?

Will I be able to work or will I be at home in bed? For how long?

What should I do about diet and exercise while I'm getting treatments?

Will I be able to have children after my treatment?

What's my prognosis?

If I go through all the treatments as you prescribe, what are the chances that the cancer will come back?

If the cancer returns, what do we do then?

References

Lacey JV Jr, Mink PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002 Jul 17;288(3):334-41. Erratum in: JAMA 2002 Nov 27;288(20):2544.

Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM; Women's Health Initiative Investigators. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA. 2003 Oct 1;290(13):1739-48.

"Ovarian Risk Tied to Body Size" American Cancer Society. Nov. 9, 2001. http://www.cancer.org. Accessed Sept. 2004.

"Breakthrough Helps Ovarian Cancer Patients Beat Odds" National Ovarian Cancer Coalition. http://www.ovarian.org. Accessed Sept. 2004.

"Ovarian Cancer." CancerNet. National Cancer Institute. National Institutes of Health. http://www.cancer.gov. Accessed Sept. 2004.

"What Every Woman Should Know About Cancer." National Ovarian Cancer Coalition, http://www.ovarian.org. Accessed Dec. 2001.

"Ovarian, Uterine & Colon Cancers: Be Aware." National Women's Health Resource Center Health Report. Vol. 21, No. 1. February 1999.

Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002 Feb 16;359(9306):572-7.

American Cancer Society. Cancer Facts and Figures, 2004..Available at: http://www.cancer.org. Accessed September 9, 2004.

Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004 Jun 9;291(22):2705-12

Questions and Answers: OvaCheckT and NCI/FDA Ovarian Cancer Clinical Trials Using Proteomics Technology. National Cancer Institute. [Press release]. Available at http://www.cancer.gov. Accessed July 20, 2004.

Conrads TP, Fusaro VA, Ross S, et.al., High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer. 2004 Jun;11(2):163-78.

"Questions and answers about the CA-125 test." Johns Hopkins Pathology. August 2003. http://ovariancancer.jhmi.edu. Accessed April 2006.

"How is ovarian cancer found?" The American Cancer Society. March 2006. http://www.cancer.org. Accessed April 2006.

"How is ovarian cancer treated?" The American Cancer Society. March 2006. http://www.cancer.org. Accessed April 2006.

"What's new in ovarian cancer treatment and research?" The American Cancer Society. March 2006. http://www.cancer.org. Accessed April 2006.

"Can ovarian cancer be prevented?" The American Cancer Society. March 2006. http://www.cancer.org Accessed April 2006.

"What are the key statistics about ovarian cancer?" The American Cancer Society. March 2006. http://www.cancer.org. Accessed April 2006.

"Do we know what causes ovarian cancer?" The American Cancer Society. March 2006. http://www.cancer.org. Accessed April 2006.

"Questions and answers about Doxil." Doxil.com. http://72.14.203.104. Accessed April 2006.

"Treatment for Epithelial Ovarian Cancers by Stage." The American Cancer Society. March 2006. http://www.cancer.org. Accessed April 2006.

"Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer." Clinicaltrials.gov. March 2006. http://www.clinicaltrials.gov. Accessed April 2006.

Keywords: Endometrium,Keloids,Malignant,Nicotine,Anti-La,Breast implant